Is Brainstorm Cell Therapeutics, Inc (BCLI) Stock a Good Buy for Short-term Investors?
At the time of writing, Brainstorm Cell Therapeutics, Inc [BCLI] stock is trading at $1.12, up 14.87%. An important factor to consider is whether the stock is rising or falling in short-term value. The BCLI shares have gain 30.23% over the last week, with a monthly amount drifted -17.04%, and not seem to be holding […]
